Q2 2025 Earnings Conference Call July 17, 2025 4:00 AM ETCompany ParticipantsChristian Cederholm - CEO, President ...

Excitement among those who happen to love women’s football continues to mount as the 2025 UEFA Women’s European Championship ...

Excitement among those who happen to love women’s football continues to mount as the 2025 UEFA Women’s European Championship ...

Sunday's battering of Wales allowed the likes of Lauren James, Alessia Russo and Ella Toone to get some rest - they'll all be ready to go again ...

And is there anything that the city and the electric utility could be doing to decrease that likelihood – or, at least, ...

This study offers important insights into the development of infants' responses to music based on the exploration of EEG neural auditory responses and video-based movement analysis. The convincing ...

What is today’s moon phase? As of Thursday, July 3, the moon phase is Waxing Gibbous. According to NASA's Daily Moon Observation, 57% of the moon will be lit up and visible to us on Earth.

Topline results were announced from a phase 3 study evaluating secukinumab in adults with newly diagnosed or relapsing giant cell arteritis (GCA).

These three Chicago Bears veterans could be facing the chopping block if they don't have a strong 2025 training camp.

The phase 3 IRAKLIA trial assesses subcutaneous isatuximab via on-body injector vs intravenous (IV) administration, in combination with pomalidomide and dexamethasone, in relapsed/refractory ...

With what Insmed calls an "outstanding" phase 2 win for its treprostinil palmitil inhalation powder (TPIP) in patients with pulmonary arterial hypertension (PAH), the company is racing to phase 3 ...

Denifanstat showed positive Phase 3 results in acne, meeting all goals with strong safety, as Sagimet pushes ahead with a second FASN inhibitor trial.